FIGURE 4.
Quantitative immunohistochemistry for LC3, p62, and TDP-43: sporadic inclusion body myositis (sIBM) to HIV-inclusion body myositis (HIV-IBM) comparison. (A–C) There was no significant difference in the percentage of (A) LC3-, (B) p62-, and (C) TDP-43-positive fibers between patients with sIBM and HIV-IBM; the sIBM cohort data were reported previously (14). Each biopsy is represented with a symbol; the lines designate group means.